Shawn Egan

Stock Analyst at Citigroup

(1.97)
# 3,116
Out of 4,980 analysts
5
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Neutral
Price Target: $21$17
Current: $29.72
Upside: -42.80%